Organization | University Hospital Koge

University Hospital Koge Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Founded: Køge Denmark (1983)

Organization Overview

First Clinical Trial

2007

NCT00526006

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2016

Timeline

NOW

Now

Alternative names

University Hospital KÃ¸ge | University Hospital Koege

Active Ingredients

Drugs in Phase 4 Trials (6)

esomeprazole (nexium) (1 trial)

insulin detemir (Levemir) (1 trial)

insulin lispro (humalog) (1 trial)

pantoprazole (protonix) (1 trial)

protamine insulin (1 trial)

sitagliptin (januvia) (1 trial)

Drugs in Phase 3 Trials (4)

allopurinol (zyloprim) (1 trial)

azathioprine (imuran) (1 trial)

sodium chloride (1 trial)

Drugs in Phase 1 Trials (1)

melatonin (1 trial)

Drugs in Other Trials (2)

kit for iodinated I-125 albumin (Jeanatope) (1 trial)

radiolabeled albumin technetium Tc-99m albumin colloid kit (Microlite) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Arteriosclerosis (Phase 4)

Atherosclerosis (Phase 4)

Colitis (Phase 3)

Colitis, Ulcerative (Phase 3)

Dyspepsia (Phase 4)

Hernia (Phase 3)

Hernia, Femoral (Phase 3)

Hernia, Inguinal (Phase 3)

Ulcer (Phase 3)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 13